DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
FDA.
Evaluation of automatic class III designation for ContaCT.
Decision Summary. Accessed April 18, 2021 at:
https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170073.pdf
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.